{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "13235", "DateCompleted": {"Year": "1977", "Month": "03", "Day": "21"}, "DateRevised": {"Year": "2019", "Month": "10", "Day": "27"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0361-1124", "JournalIssue": {"Volume": "6", "Issue": "2", "PubDate": {"Year": "1977", "Month": "Feb"}}, "Title": "JACEP", "ISOAbbreviation": "JACEP"}, "ArticleTitle": "Jimson seed poisoning-- a new hallucinogen on the horizon.", "Pagination": {"StartPage": "58", "EndPage": "61", "MedlinePgn": "58-61"}, "Abstract": {"AbstractText": ["Of 27 patients with Jimson seed poisoning recently treated in the University of Cincinnati Medical Center, 15 were admitted to the hospital, while 12 were treated and released. The patients ranged in age from 13 to 21. The dose was between 2 gm and 25 gm. Time from ingestion to arrival in the emergency department averaged 12.1 hours for those admitted and 10 hours for those who were not. All patients had altered mental status. Twenty-five of the 27 received Ipecac and all but one received at least 2 mg of physostigmine, which produced dramatic improvement in central nervous system symptoms. The authors have developed a management protocol based on physiologic criteria."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Levy", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "JACEP", "NlmUniqueID": "0317011", "ISSNLinking": "0361-1124"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hallucinogens"}, {"RegistryNumber": "8012-96-2", "NameOfSubstance": "Ipecac"}, {"RegistryNumber": "9U1VM840SP", "NameOfSubstance": "Physostigmine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["poisoning"], "DescriptorName": "Datura stramonium"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["poisoning"], "DescriptorName": "Hallucinogens"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ipecac"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Physostigmine"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1977", "Month": "2", "Day": "1"}, {"Year": "1977", "Month": "2", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1977", "Month": "2", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["13235", "10.1016/s0361-1124(77)80035-x", "S0361-1124(77)80035-X"]}}]}